Purchases and Sales Made in Q1 2024 in Protagonist Therapeutics, Inc (PTGX)
This table provides information about the institutional ownership of Protagonist Therapeutics, Inc (PTGX) during Q1 2024. The information is specifically focused on institutions that hold shares of Protagonist Therapeutics, Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 09, 2024
Q1 2024
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-14.4K- 13.35% |
$313K - $462K
|
93.2K
$4.44M
|
|
|
May 15, 2024
Q1 2024
|
683 Capital Management, LLC
New York, NY |
SELL
|
- |
-15K- 2.1% |
$327K - $482K
|
700K
$33.3M
|
|
|
May 14, 2024
Q1 2024
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-17.4K- 38.03% |
$379K - $560K
|
28.4K
$1.35M
|
|
|
May 10, 2024
Q1 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-25.2K- 3.09% |
$549K - $810K
|
791K
$37.7M
|
|
|
May 15, 2024
Q1 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-25.3K- 11.4% |
$551K - $813K
|
197K
$9.37M
|
|
|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-37.9K- 34.52% |
$825K - $1.22M
|
71.8K
$3.42M
|
|
|
May 15, 2024
Q1 2024
|
Soleus Capital Management, L.P.
Greenwich, CT |
SELL
|
- |
-48.5K- 58.43% |
$1.06M - $1.56M
|
34.5K
$1.64M
|
|
|
May 15, 2024
Q1 2024
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-50K- 40.0% |
$1.09M - $1.61M
|
75K
$3.57M
|
|
|
May 15, 2024
Q1 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-51.3K- 27.67% |
$1.12M - $1.65M
|
134K
$6.39M
|
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-87.2K- 58.5% |
$1.9M - $2.8M
|
61.8K
$2.94M
|
|
|
May 13, 2024
Q1 2024
|
Jefferies Financial Group Inc.
New York, NY |
SELL
|
- |
-90K- 7.08% |
$1.96M - $2.89M
|
1.18M
$56.2M
|
|
|
May 15, 2024
Q1 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-106K- 71.26% |
$2.32M - $3.42M
|
42.9K
$2.04M
|
|
|
May 15, 2024
Q1 2024
|
Eversept Partners, LP
New York, NY |
SELL
|
- |
-127K- 23.53% |
$2.76M - $4.07M
|
411K
$19.6M
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-174K- 42.24% |
$3.78M - $5.58M
|
237K
$11.3M
|
|
|
May 03, 2024
Q1 2024
|
Candriam S.C.A.
|
SELL
|
- |
-177K- 32.96% |
$3.86M - $5.69M
|
360K
$17.1M
|
|
|
May 13, 2024
Q1 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-181K- 84.78% |
$3.95M - $5.83M
|
32.6K
$1.55M
|
|
|
May 15, 2024
Q1 2024
|
Kynam Capital Management, LP
Princeton, NJ |
SELL
|
- |
-861K- 42.93% |
$18.8M - $27.7M
|
1.14M
$54.5M
|
|
|
May 15, 2024
Q1 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-1.41M- 54.09% |
$30.8M - $45.4M
|
1.2M
$57.1M
|
|
|
May 15, 2024
Q1 2024
|
Bvf Inc
San Francisco, CA |
SELL
|
- |
-1.99M- 34.62% |
$43.3M - $63.9M
|
3.76M
$179M
|